BioNTech Bolsters Cancer Immunotherapy Ambitions In Pact With Cash-Poor Ryvu

 
• By Joseph Haas
  
Cash infusion
Ryvu gets needed infusion of cash in tie-up with BioNTech • Source: Shutterstock

More from Deals

More from Business